Shows
American Journal of Gastroenterology Author PodcastsACG and CAG Clinical Guideline: Management of DyspepsiaPaul Moayyedi, MB, ChB, PhD, MPH, FACG, co-author of new guidelines on management of dyspepsia, discusses the evolving definition and diagnosis of dyspepsia, when and when not to use endoscopy, and how H. pylori factors into dyspepsia treatment. (30:14)2017-07-0530 minAmerican Journal of Gastroenterology Author PodcastsACG Clinical Guideline on Small Bowel BleedingLauren Gerson, MD, MSc, FACG, co-author of the new ACG Clinical Guideline on small bowel bleeding talks with AJG Co-Editor Dr. Paul Moayyedi about recommended diagnostic techniques, including second look endoscopy, capsule endoscopy, push enteroscopy, and double-balloon enteroscopy. Efficacy of hormonal therapies, somatostatin analogs, biologic therapy, and angiogenic therapy is discussed, as well as the role of anticoagulants in the management of patients with obscure bleeding. (20:28)2015-09-0920 minAmerican Journal of Gastroenterology Author PodcastsACG Clinical Guideline on Primary Sclerosing CholangitisKeith D. Lindor, MD, FACG, co-author of the new ACG Clinical Guideline on primary sclerosing cholangitis talks with AJG Co-Editor Dr. Paul Moayyedi about recommended diagnostic techniques, symptom management strategies, and the role of liver transplantation. Recommendations for colon and cholangiocarcinoma surveillance are also discussed. (18:18)2015-05-0520 minAmerican Journal of Gastroenterology Author PodcastsACG Monograph on the Management of IBS and Chronic Idiopathic Constipation-A Podcast with Eamonn M.M. Quigley, MD, FACG and Paul Moayyedi, BSc, MB ChB, PhD, MPH, FACGDrs. Eamonn Quigley and Paul Moayyedi, co-authors of the new ACG Monograph on the management of IBS and CIC, talk with AJG Co-Editor Dr. William D. Chey about the rapidly changing field of IBS and CIC treatments, the new relevance of products such as probiotics and antibiotics in altering the microbiome in IBS patients, recommendations for PEG and newer prosecretory agents in IBS-C and CIC, and the use of drugs such as alosetron and ondansetron for severe IBS-D. (22:44)2014-10-2924 minAmerican Journal of Gastroenterology Author PodcastsNew Practice Guidelines on Achalasia-A Podcast with Michael F. Vaezi, MD, FACG, John E. Pandolfino, MD, and Marcelo F. Vela, MDMichael F. Vaezi, MD, FACG, John E. Pandolfino, MD, and Marcelo F. Vela, MD, co-authors of the American College of Gastroenterology's new Clinical Guideline on the Diagnosis and Management of Achalasia published in the August issue of AJG, talk with co-Editor Dr. Paul Moayyedi about the incidence, prevalence, and diagnosis of this disorder; the best treatment options-including myotomy, pneumatic dilatation, and botulinum toxin-according to achalasia subtype and patient age, gender, and preference; as well as the long-term outlook and risks for achalasia patients after successful therapy.2013-08-0125 minAmerican Journal of Gastroenterology Author PodcastsHigh Economic Burden of Caring for Patients With Suspected Extraesophageal Reflux-A Podcast with Michael F. Vaezi, MD, FACG, and David O. Francis, MDMichael F. Vaezi, MD, FACG, and David O. Francis, MD, co-authors of new research on the high costs of caring for patients with extraesophageal reflux symptoms published in the June issue of AJG, talk with AJG co-Editor Dr. Paul Moayyedi about the prevalence of various extraesophageal reflux symptoms, the costs of treating these symptoms, the impact of tertiary care centers in both patient improvement and health care costs, and whether the best treatment for extraesophageal reflux is perhaps no treatment at all.2013-07-0226 minAmerican Journal of Gastroenterology Author PodcastsNew Practice Guidelines on Esophageal Eosinophilia and Eosinophilic Esophagitis (EoE)-A Podcast with David A. Katzka, MD, FACGDavid A. Katzka, MD, FACG, co-author of the American College of Gastroenterology's new Clinical Guideline on the Diagnosis and Management of Esophageal Eosinophilia and Eosinophilic Esophagitis (EoE), talks with AJG Co-editor Dr. Paul Moayyedi about the key components of the guidelines, including the epidemiology of the disease, the difficulty of diagnosis for EoE, the role of diet and pharmacological therapy for treatment of EoE, and the urgent need for more research into this disease.2013-05-0640 minAmerican Journal of Gastroenterology Author PodcastsExpert Author Insight: New Practice Guidelines on GERD—A Podcast with Philip O. Katz, MD, FACG and Lauren B. Gerson, MD, MSc, FACGPhilip O. Katz, MD, FACG and Lauren B. Gerson, MD, MSc, FACG, two authors of the American College of Gastroenterology’s new Practice Guidelines for the Diagnosis and Management of Gastroesophageal Reflux Disease (GERD), talk with AJG Co-editor Paul Moayyedi, MD, FACG, about the key components of the guidelines, including the prevalence of GERD, the recommendations for the approach to diagnosis and management, and the potential adverse events associated with PPI therapy.2013-03-2033 minAmerican Journal of Gastroenterology Author PodcastsClinical Guideline: Management of GastroparesisThe American Journal of Gastroenterology (AJG) Co-Editor Paul Moayyedi, MD, FACG, talks with Henry P. Parkman, MD, FACG, of Temple University, one of the lead authors of a new clinical guideline for the management of gastroparesis. Published in the January issue of AJG, the guideline addresses the definition, diagnosis, differential diagnosis, and treatment of gastroparesis, including nutritional supplementation, glycemic control, pharmacological, endoscopic, device, and surgical therapy. Dr. Parkman provides insight on the guideline’s key recommendations, including the scientifically-based evidence behind them.2013-01-2226 minAmerican Journal of Gastroenterology Author PodcastsA 12-week, randomized controlled trial with a 4-week randomized withdrawal period to evaluate the efficacy and safety of linaclotide in irritable bowel syndrome with constipationAJG Journal co-editor Dr. Paul Moayyedi talks with William D. Chey, MD, FACG and Satish Rao, MD, PhD, FACG about to two randomized controlled trials on linaclotide in irritable bowel syndrome (IBS) published in the December issue of The American Journal of Gastroenterology. The phase 3 trials report that this new therapy significantly reduces constipation and abdominal pain associated with some kinds of IBS.2012-11-2835 minAmerican Journal of Gastroenterology Author PodcastsThe Prevalence of Irritable Bowel Syndrome Symptoms in Inflammatory Bowel DiseaseAJG Co-Editor Paul Moayyedi, MD, FACG, talks with Alexander C. Ford, MD, and Eamonn M. M. Quigley, MD, FACG, about the findings from the first systematic review of the literature of irritable bowel syndrome symptoms in inflammatory bowel disease. In the review, Dr. Ford and his co-investigator Stephen J. Halpin, MD, demonstrated that prevalence of symptoms compatible with IBS in patients with IBD is as high as 40%. This article and Dr. Quigley’s editorial “Irritable Bowel Symptoms in IBD: Diagnostic Uncertainty Meets Pathological Reality” were published in the October issue of the AJG.2012-09-1823 min